Recent Updates Page 2 RSS Back to NoCamels

  • mayay 2:15 pm on October 21, 2014 Permalink
    Tags: , brainsway depression treatment, brainsway in europe, dTMS, , israel brain stimulation,   

    Brainsway Signs Marketing Agreement With French Co. 

    brainsway logoOctober 21, 2014 | The Israeli company Brainsway has reportedly signed a marketing agreement with a French company for its Deep TMS System in France. Brainsway’s Deep TMS (Deep Transcranial Magnetic Stimulation) system is a treatment for depression and other brain disorders that has been approved by the FDA in the United States for the treatment of severe depression. According to the agreement, Brainsway will deal directly with customers recruited by the French company, while paying the latter company a commission for every new customer. In addition, Brainsway announced that BlueCross BlueShield will begin to reimburse patients for Brainsway treatments in the US states of Flordia, Kansas and Missouri, and that Tufts will do so in Massachusetts.

     
  • mayay 2:06 pm on October 21, 2014 Permalink
    Tags: digital communications incubators, , , telefonica israel, van leer ventures, vlx ventures incubator,   

    VLX Ventures To Collborate With Telefonica 

    vanleerventuresOctober 21, 2014 | The international telecommunications company Telefonica will work together with VLX Ventures technology incubator jointly owned by Van Leer Ventures and Xenia Venture Capital. As part of the cooperation agreement, Telefonica will examine the VLX incubator’s projects in the digital communications sector, investing up to $1 million in promising projects. The collaboration will focus on video, cloud computing, big data, Internet of things and future communications. Telefonica was founded in 1924 in Spain and has been active in Israel since 2010.

     
  • mayay 1:51 pm on October 21, 2014 Permalink
    Tags: , , , israel research cooperation, jericho buttons, leshimaniasis studies, pharmaseed   

    Israel, Jordan And Switzerland Cooperate In Leshimaniasis Study 

    pharmaseedlogoOctober 21, 2014 | In a new project initiated by Israeli research company Pharmaseed, Israeli, Jordanian and Swiss researchers will work together to find a treatment for leshimaniasis. Cutaneous leishmaniasis is a parasitic skin disease also known as “Jericho buttons” that is transmitted by sand flies and is common in the Middle East. Four partners have already been recruited for the project: the Dead Sea and Arava Science Center, the Swiss Tropical and Public Health Institute and Pharmaseed, which will coordinate the project and will be responsible for safety tests, and the Jordan University of Science and Technology. Pharmaseed was founded in 2003 and is Israel’s largest GLP-certified pre-clinical CRO specializing in pre-clincial studies.

     
  • mayay 2:02 pm on October 20, 2014 Permalink
    Tags: ateras, bluephoenix, bluephoenix merger, , , modern systems,   

    BluePhoenix Merges With Ateras In Share Deal To Form Modern Systems 

    bluephoenixOctober 20, 2014 | Software conversion company BluePhoenix Solutions, headquartered in Israel, will merge with Ateras Sophisticated Business Systems in a share deal to form Modern Systems. According to the deal, BluePhoenix will issue 6.2 million shares at a value of $22.7 million, a value that constitutes a third of its capital, to Ateras shareholders in exchange for Ateras’ entire capital. Reports found that the two companies had an aggregate of $14.3 million in revenue in 2013. BluePhoenix, founded in 1987 and formerly controlled by Formula Systems, has a NASDAQ market cap of $42 million and is set to downsize its Israeli office following the merger.

     
  • mayay 1:47 pm on October 20, 2014 Permalink
    Tags: , , israeli biomedical companies nasdaq, , israeli company ipos, , releasing drugs into the bones   

    PolyPid Set To File For $23M IPO On NASDAQ 

    PolyPidLogoClearOctober 20, 2014 | The orthopedic drug developer PolyPid published an open draft prospective for raising $23 million in a NASDAQ public offering. While no company value was listed, it is believed that the company will be valued at about $100 million, after money. The offering will be led by Aegis with MLV and Chardan Capital acting as secondary underwriters and is set to take place next month. PolyPid’s primary shareholder is the Xenia incubator and has raised $12.7 million to date. PolyPid has developed an implant that releases drugs into the bones, with applications in the dental and medical sectors, which is set to begin clinical trials in the US and Europe in 2015.

     
  • mayay 1:36 pm on October 20, 2014 Permalink
    Tags: asus padfone x, , ceva semiconductors and chips, , padfone x, tablet and smartphone in one,   

    Asus PadFone X Contains Ceva Component 

    cevaOctober 20, 2014 | The semiconductor and chip company Ceva produced a component in the new Asus hybrid smartphone-tablet. Just last week, Asus announced the release of the PadFone X, a new device that will be sold in the United States by communications provider AT&T for approximately $200. Intel’s communications chip and Ceva’s digital signals processor are two of the major technologies in the new PadFone X. Ceva currently trades on NASDAQ at a market cap of $281 million. Ceva was founded in 2002 when the licensing division of DSP Group merged with Parthus Technologies. The company is headquartered in California, but its main R&D center is located in Herzliya, Israel.

     
  • mayay 1:17 pm on October 20, 2014 Permalink
    Tags: , , , , radware, radware security contracts, roy zisapel, , us financial companies cyber security   

    Radware Signs Multi-Million Dollar Cyber Security Contract 

    radwareOctober 20, 2014 | Radware, the Israeli company specializing in directing Internet traffic loads, announced that it signed a multi-million dollar contract with a US financial services company. According to the contract, Radware will provide protection against cyber attacks by spotting and preventing attacks in real time without human intervention and without disrupting Internet traffic. VP of Security Solutions stated of the deal, “Financial entities are in the forefront of the cyber attacks, and high quality identification and reduction of such attacks in real time is critical.” Radware was founded as a provider of application delivery and security solutions for virtual and cloud data centers in 1997 and is headed by CEO Roy Zisapel.

     
  • mayay 12:58 pm on October 20, 2014 Permalink
    Tags: check-cap, , ge healthcare investment, , , israeli colon cancer treatments, xray pill for colon cancer   

    Check-Cap Raises $12M From Fosun Pharma 

    checkcapOctober 20, 2014 | Israeli pharmaceutical technology company Check-Cap raised $12 million in a private placement round led by Chinese company Fosun Pharma. Previous investors also participated in the round, including GE Healthcare, Docor, Pontifax, the Counterpoint Fund, MNS and others. The current financing round is a line of credit from which Check-Cap can pull a total of $12 million. In addition, according to “Globes,” Check-Cap recently renewed consideration its NASDAQ public offering. Check Cap is developing a pill that conducts an X-Ray scan on intestines in order to detect colon cancer. Check-Cap was founded in 2005 by company CTO Dr. Yoav Kimchy.

     
  • NoCamels Team 5:01 pm on October 19, 2014 Permalink
    Tags: california israel chamber of commerce, california-israel cooperation, conferences, first annual international business summit california israel, , israel-us tech conferences, sharing israel's tech knowledge,   

    California Israel Chamber Of Commerce Holds First Annual Int’l Business Summit 

    californiaisraelchamberOctober 19, 2014 | The California Israel Chamber of Commerce (CICC) together with the Israeli Economic Mission to the West Coast and other governmental bodies announced the first annual California Israel International Business Summit. At the conference, the topics of exciting trends in cyber security, big data, cloud, the Internet of Things. mobile and new media will be discussed. The summit will be held on October 22, 2014 in Mountain View, California. The conference will feature panel discussions, keynote speakers, 26 up-and-coming Israeli companies and a review of the industry’s biggest trends. “We are particularly excited to bring together so many technology leaders, dynamic entrepreneurs, industry experts, and investors from Brazil, Canada, India, Israel, South Korea, the United States, and other countries onsite to share their expertise and explore potential collaboration with presenting companies,” said Talia Cohen, Executive Director of The California Israel Chamber of Commerce.

     
  • NoCamels Team 4:49 pm on October 19, 2014 Permalink
    Tags: best tel aviv transportation, , israel transit authority, israel transportation news, israel transportation tel aviv, parsons brinckerhoff, tel aviv light rail, transportation news   

    Israeli Transit Authority Will Pay $233M To See Tel Aviv Light-Rail Done Right 

    parsonsbrinckherhoffOctober 19, 2014 | Israel’s National Transportation Authority (NTA), responsible for the Tel Aviv-area light-rail project, announced that it is in the final stages of negotiations with Parsons Brinckerhoff for a management agreement without tender. According to the agreement, American global consulting firm Parsons Brinckerhoff will be paid $233 million in order to manage the Tel Aviv light-rail system currently under construction for a period of 10 years. Parsons Brinckerhoff is an international company that provides professional energy and infrastructure services, with over 14,000 employees. The company is well known for its extensive knowledge in producing efficient and effective railway plans.

     
c
compose new post
j
next post/next comment
k
previous post/previous comment
r
reply
e
edit
o
show/hide comments
t
go to top
l
go to login
h
show/hide help
shift + esc
cancel